To access this element change to forms mode OFF
Grant Award View - GA216978
Harnessing the beneficial off-target effects of BCG vaccination to boost...
GA ID:
GA216978
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,207,211.85
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Harnessing the beneficial off-target effects of BCG vaccination to boost protection against SARS-CoV-2
Purpose:
Bacillus Calmette–Guérin(BCG), the vaccine that protects against tuberculosis, also protects against other diseases. This is thought to be because BCG can boost immunity. We will investigate how BCG boosts immune responses to SARS-CoV-2 and if this improves protection against COVID-19 and the effectiveness of COVID-19 vaccines. We will combine use of mouse models with use of samples from BRACE, our 6800 participant trial testing if BCG vaccination protects against COVID-19 in healthcare workers.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012769
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Murdoch Childrens Research Institute
Recipient ABN:
21 006 566 972
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, BRAZIL, NETHERLANDS